Skip to content

HFNO Improves Blood Oxygen Saturation During Asphyxia During Pulmonary Surgery With Double-lumen Endotracheal Intubation

High-flow Nasal Oxygenation Improves Blood Oxygen Saturation During Asphyxia During Pulmonary Surgery With Double-lumen Endotracheal Intubation: a Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05666908
Enrollment
112
Registered
2022-12-28
Start date
2023-01-31
Completion date
2024-12-31
Last updated
2022-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms, Pneumothorax

Brief summary

With the continuous strengthening of the concept of rapid rehabilitation, great progress has been made in minimally invasive thoracic surgery, and thoracoscopic surgery has developed rapidly. Double-lumen endotracheal(DLT) intubation is still the most reliable way of intubation in lung surgery. However, hypoxemia faced during double-lumen intubation still threatens the perioperative safety of thoracic surgery patients. In recent years, high-flow nasal oxygenation (HFNO) has great potential in the field of anesthesia, especially playing a new and important role in the prevention and treatment of short-term hypoxia and life-threatening airway emergencies. However, the use of HFNO in pulmonary surgery patients with poor pulmonary function lacks evidence-based basis, and there are few reliable clinical data. This study adopted a prospective, randomized, controlled, single-blind design. A total of 100 patients aged 18-60 years who underwent elective thoracoscopy-assisted pulmonary surgery were included and randomly divided into the experimental group: HFNO was used in the process of double-lumen intubation asphyxia; the control group: according to the traditional intubation process, No oxygen therapy equipment was used during intubation asphyxiation. The lowest blood oxygen saturation during intubation, the incidence of hypoxemia during intubation, perioperative complications, and postoperative hospital stay were compared between the two groups. This study explores the advantages of HFNO in complex endotracheal intubation, assuming that HFNO can improve the oxygen saturation of double-lumen intubation; optimize the intubation method of DLT, and tap its new potential to prevent and manage emergency airway crisis.

Interventions

DEVICEHFNO

After the patient's mask-assisted ventilation makes the end-expiratory oxygen concentration (EtO2) \> 90%, wear the HFNO device according to the pre-adjusted mode (temperature 34°C, oxygen concentration 100%, flow rate 50 litres per minute). The nasal cannula will remain in place until intubation is complete (including DLT intubation, direct FOB guidance, and DLT alignment with FOB). After securing the HFNO device, the glottis was exposed using a laryngoscope, and the DLT main tracheal cuff was passed through the glottis and paused under direct vision. Insert the DLT into the bronchial tube lumen of the DLT using the FOB, and then advance the DLT into the corresponding main bronchus under the guidance of the FOB. After confirming the appropriate depth of the catheter using the FOB, insert the DLT into the anesthesia machine to complete the intubation process. After the DLT was connected to the anesthesia machine and mechanical ventilation was started, the HFNO device was removed.

Sponsors

Shenzhen Second People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-60; * Patients planning to undergo video-assisted thoracoscopic (VATS) lung surgery requiring DLT intubation; * Patients who agreed to participate in this study.

Exclusion criteria

* American Society of Anesthesiologists (ASA) classification \> IV; * Patients with severe nasal obstruction; expected difficult intubation or difficulty with mask ventilation; * Morbid obesity \[Body Mass Index (BMI)\>35kg/m2)\]; * Airway anatomical abnormalities; * Abnormal coagulation function; * Emergency surgery; * Patients at high risk of reflux aspiration, including ileus, full stomach, esophageal reflux disease; * Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frameDescription
Minimum blood oxygen saturation (SpO2)After the DLT intubationMinimum SpO2 measured by capillary oximeter during DLT intubation. SpO2 was continuously monitored by the monitor every 1 second and recorded every 5 seconds, and the lowest SpO2 was recorded through the monitor by the recording personnel who were not involved in anesthesia management.

Secondary

MeasureTime frameDescription
The incidence of lowest SpO2<90%After the DLT intubationMinimum SpO2 measured by capillary oximeter during DLT intubation. SpO2 was continuously monitored by the monitor every 1 second and recorded every 5 seconds, and the lowest SpO2 was recorded through the monitor by the recording personnel who were not involved in anesthesia management.
The incidence of lowest SpO2<95%After the DLT intubationMinimum SpO2 measured by capillary oximeter during DLT intubation. SpO2 was continuously monitored by the monitor every 1 second and recorded every 5 seconds, and the lowest SpO2 was recorded through the monitor by the recording personnel who were not involved in anesthesia management.
DLT intubation timeAfter the DLT intubationThe DLT intubation period was defined as: from the time the video laryngoscope was placed in the oral cavity, to the confirmation of the correct position of the DLT by the FOB, and the end of the insertion of the anesthesia machine.
End-tidal carbon dioxide partial pressure after intubationAfter the DLT intubationWhen the tracheal intubation is completed, the monitor displays the partial pressure of carbon dioxide at the end of the first mechanical ventilation.
End-tidal oxygen concentration after intubationAfter the DLT intubationWhen the tracheal intubation is completed, the monitor displays the end-expiratory oxygen concentration of the first mechanical ventilation.
The incidence of difficult airwayAfter the DLT intubationDifficult airway was defined as failure of videolaryngoscope intubation, switch to fiberoptic bronchoscope-guided intubation.
The incidence of bronchial dislocationAfter the DLT intubationLeft or right bronchial tube strayed into right or left bronchus.
Operator satisfaction with intubationAfter the DLT intubationOperator satisfaction rating for intubation (range 0-10, with 0 being very dissatisfied and 10 being very satisfied).
The incidence of low blood oxygen saturation (SpO2<90%) in the post-anaesthesia care unit (PACU)Up to 1 weekAfter the patient entered the PACU, the blood oxygen saturation was continuously monitored and the lowest blood oxygen saturation value was recorded.
The incidence of postoperative airway-related complications1st, 2nd and 3rd day after surgeryPostoperative airway-related complications include: sore throat, hoarseness, and nasopharyngeal dryness.
The incidence of nausea and vomiting1st, 2nd and 3rd day after surgeryInterview patients' subjective feelings, including nausea and vomiting.
Patient satisfaction with anesthesiaThe first day after surgeryPatient satisfaction with anesthesia(range 0-10, with 0 being very dissatisfied and 10 being very satisfied).
Postoperative hospital stayThrough study completion, an average of 4 weeksThe medical record system queries the number of days in hospital after surgery.
The incidence of postoperative complicationThrough study completion, an average of 4 weeksPostoperative complications included postoperative atelectasis, pneumothorax, pulmonary infection, pleural effusion, bronchopleural fistula and postoperative bleeding.
Incidence of related complications during intubationAfter the DLT intubationAssociated complications during intubation include: reflux aspiration, laryngospasm or bronchospasm, tracheal or bronchial tear, barotrauma, systolic blood pressure \< 90 mmHg or initiation of vasoactive drugs, systolic blood pressure \> 180 mmHg, severe arrhythmias, and lips or tooth damage.

Contacts

Primary ContactNanbo Luo, MD.
316916645@qq.com+86-15112389303

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026